143 related articles for article (PubMed ID: 34892030)
21. CT-based deep learning enables early postoperative recurrence prediction for intrahepatic cholangiocarcinoma.
Wakiya T; Ishido K; Kimura N; Nagase H; Kanda T; Ichiyama S; Soma K; Matsuzaka M; Sasaki Y; Kubota S; Fujita H; Sawano T; Umehara Y; Wakasa Y; Toyoki Y; Hakamada K
Sci Rep; 2022 May; 12(1):8428. PubMed ID: 35590089
[TBL] [Abstract][Full Text] [Related]
22. Radiomics signature on dynamic contrast-enhanced MR images: a potential imaging biomarker for prediction of microvascular invasion in mass-forming intrahepatic cholangiocarcinoma.
Zhou Y; Zhou G; Zhang J; Xu C; Wang X; Xu P
Eur Radiol; 2021 Sep; 31(9):6846-6855. PubMed ID: 33638019
[TBL] [Abstract][Full Text] [Related]
23. Radiomics-based model for predicting early recurrence of intrahepatic mass-forming cholangiocarcinoma after curative tumor resection.
Zhu Y; Mao Y; Chen J; Qiu Y; Guan Y; Wang Z; He J
Sci Rep; 2021 Sep; 11(1):18347. PubMed ID: 34526604
[TBL] [Abstract][Full Text] [Related]
24. Mass-forming intrahepatic cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes.
Ariizumi S; Kotera Y; Takahashi Y; Katagiri S; Chen IP; Ota T; Yamamoto M
J Surg Oncol; 2011 Aug; 104(2):130-9. PubMed ID: 21448898
[TBL] [Abstract][Full Text] [Related]
25. Radiomics model of magnetic resonance imaging for predicting pathological grading and lymph node metastases of extrahepatic cholangiocarcinoma.
Yang C; Huang M; Li S; Chen J; Yang Y; Qin N; Huang D; Shu J
Cancer Lett; 2020 Feb; 470():1-7. PubMed ID: 31809800
[TBL] [Abstract][Full Text] [Related]
26. The value of an MRI-based radiomics model in predicting the survival and prognosis of patients with extrahepatic cholangiocarcinoma.
Wang L; Liu J; Zeng Y; Shu J
Cancer Med; 2024 Jan; 13(1):e6832. PubMed ID: 38186299
[TBL] [Abstract][Full Text] [Related]
27. Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma.
Asayama Y; Yoshimitsu K; Irie H; Tajima T; Nishie A; Hirakawa M; Nakayama T; Kakihara D; Taketomi A; Aishima S; Honda H
Radiology; 2006 Jan; 238(1):150-5. PubMed ID: 16304089
[TBL] [Abstract][Full Text] [Related]
28. Mass-forming intrahepatic cholangiocarcinoma presenting tumor growth in extrahepatic bile duct and superficial spreading.
Regimbeau JM; Panis Y; Nemeth J; Pocard M; de Claviere G; Soyer P; Valleur P
Hepatogastroenterology; 2003; 50(49):21-3. PubMed ID: 12629982
[TBL] [Abstract][Full Text] [Related]
29. Machine learning: an approach to preoperatively predict PD-1/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers.
Zhang J; Wu Z; Zhang X; Liu S; Zhao J; Yuan F; Shi Y; Song B
ESMO Open; 2020 Nov; 5(6):e000910. PubMed ID: 33239315
[TBL] [Abstract][Full Text] [Related]
30. A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience.
Hyder O; Marques H; Pulitano C; Marsh JW; Alexandrescu S; Bauer TW; Gamblin TC; Sotiropoulos GC; Paul A; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Popescu I; Gigot JF; Mentha G; Feng S; Pawlik TM
JAMA Surg; 2014 May; 149(5):432-8. PubMed ID: 24599477
[TBL] [Abstract][Full Text] [Related]
31. A radiomics approach based on support vector machine using MR images for preoperative lymph node status evaluation in intrahepatic cholangiocarcinoma.
Xu L; Yang P; Liang W; Liu W; Wang W; Luo C; Wang J; Peng Z; Xing L; Huang M; Zheng S; Niu T
Theranostics; 2019; 9(18):5374-5385. PubMed ID: 31410221
[No Abstract] [Full Text] [Related]
32. Can machine learning radiomics provide pre-operative differentiation of combined hepatocellular cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma to inform optimal treatment planning?
Liu X; Khalvati F; Namdar K; Fischer S; Lewis S; Taouli B; Haider MA; Jhaveri KS
Eur Radiol; 2021 Jan; 31(1):244-255. PubMed ID: 32749585
[TBL] [Abstract][Full Text] [Related]
33. Novel Nomogram for Preoperative Prediction of Early Recurrence in Intrahepatic Cholangiocarcinoma.
Liang W; Xu L; Yang P; Zhang L; Wan D; Huang Q; Niu T; Chen F
Front Oncol; 2018; 8():360. PubMed ID: 30234019
[No Abstract] [Full Text] [Related]
34. Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection.
Qin H; Hu X; Zhang J; Dai H; He Y; Zhao Z; Yang J; Xu Z; Hu X; Chen Z
Liver Int; 2021 Apr; 41(4):837-850. PubMed ID: 33306240
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the Outcomes of Intrahepatic Cholangiocarcinoma After Ultrasound-Guided Percutaneous Microwave Ablation Based on Albumin-Bilirubin Grade.
Yang H; Cheng Z; Han Z; Liu F; Yu X; Yu J; Liang P
Cardiovasc Intervent Radiol; 2021 Feb; 44(2):261-270. PubMed ID: 33057809
[TBL] [Abstract][Full Text] [Related]
36. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
[TBL] [Abstract][Full Text] [Related]
37. Multidetector computed tomography in the preoperative workup of hilar cholangiocarcinoma.
Kim HJ; Lee DH; Lim JW; Ko YT
Acta Radiol; 2009 Oct; 50(8):845-53. PubMed ID: 19639473
[TBL] [Abstract][Full Text] [Related]
38. Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisation.
Mosconi C; Cucchetti A; Bruno A; Cappelli A; Bargellini I; De Benedittis C; Lorenzoni G; Gramenzi A; Tarantino FP; Parini L; Pettinato V; Modestino F; Peta G; Cioni R; Golfieri R
Eur Radiol; 2020 Aug; 30(8):4534-4544. PubMed ID: 32227266
[TBL] [Abstract][Full Text] [Related]
39. Intrahepatic mucinous cholangiocarcinoma.
Lin BY; Wu CC; Tsai TH
Kaohsiung J Med Sci; 2020 Sep; 36(9):757-758. PubMed ID: 32492241
[No Abstract] [Full Text] [Related]
40. Radiofrequency ablation in the management of unresectable intrahepatic cholangiocarcinoma.
Fu Y; Yang W; Wu W; Yan K; Xing BC; Chen MH
J Vasc Interv Radiol; 2012 May; 23(5):642-9. PubMed ID: 22525022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
